Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 7.1% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) was up 7.1% during mid-day trading on Thursday . The company traded as high as $13.47 and last traded at $13.2250. 22,403 shares were traded during trading, a decline of 50% from the average session volume of 44,764 shares. The stock had previously closed at $12.35.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold”.

Anbio Biotechnology Stock Up 7.3%

The firm’s fifty day moving average is $24.04.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.